major depressive disorder

MindMed Collaborators Announce Positive Phase II Results for LSD in Major Depressive Disorder
MindMed Collaborators Announce Positive Phase II Results for LSD in Major Depressive Disorder
Genetic Engineering News
MindMed
clinical trials
lysergide
LSD
major depressive disorder
Flag link:
Intra-Cellular reports positive Phase III trial of Caplyta in MDD and bipolar depression
Intra-Cellular reports positive Phase III trial of Caplyta in MDD and bipolar depression
Clinical Trials Arena
Intra-Cellular Therapies
clinical trials
Caplyta
major depressive disorder
bipolar disorder
Flag link:
Relmada Looks to Rebound with New Protocol After Two Phase III Flops
Relmada Looks to Rebound with New Protocol After Two Phase III Flops
BioSpace
Relmada Therapeutics
REL-1017
major depressive disorder
Flag link:
FDA says no adcomm planned for Biogen, Sage's depression drug
FDA says no adcomm planned for Biogen, Sage's depression drug
Seeking Alpha
Biogen
SAGE Therapeutics
FDA
zuranolone
major depressive disorder
postpartum depression
Flag link:
Biogen, Sage Get FDA Priority Review of Zuranolone
Biogen, Sage Get FDA Priority Review of Zuranolone
Marketwatch
Biogen
SAGE Therapeutics
FDA
zuranolone
priority review
postpartum depression
major depressive disorder
Flag link:
Small Pharma’s depressive disorder therapy trial meets primary goal
Small Pharma’s depressive disorder therapy trial meets primary goal
Clinical Trials Arena
Small Pharma
clinical trials
SPL026
major depressive disorder
Flag link:
Relmada’s MDD Drug Misses Endpoint, Marred by “Paradoxical Results”
Relmada’s MDD Drug Misses Endpoint, Marred by “Paradoxical Results”
BioSpace
Relmada
REL-1017
major depressive disorder
clinical trials
Flag link:
Ahead of FDA filing, Sage and Biogen tout more data in hopes of alleviating durability concerns
Ahead of FDA filing, Sage and Biogen tout more data in hopes of alleviating durability concerns
Endpoints
SAGE Therapeutics
Biogen
major depressive disorder
zuranolone
Flag link:
Psychedelics startup nets more than $10M in seed funding as it looks to make a splash
Psychedelics startup nets more than $10M in seed funding as it looks to make a splash
Endpoints
Freedom Biosciences
major depressive disorder
psychedelics
ketamine
FREE001
Flag link:
Praxis wields the axe as lead depression drug fails
Praxis wields the axe as lead depression drug fails
Pharmaforum
Praxis Precision Medicines
major depressive disorder
layoffs
restructuring
PRAX-114
Flag link:
Sage, Biogen get rolling on FDA submission for depression med
Sage, Biogen get rolling on FDA submission for depression med
Fierce Biotech
SAGE Therapeutics
Biogen
zuranolone
FDA
major depressive disorder
Flag link:
AbbVie sees a megablockbuster in Vraylar. Could a new depression indication push peak sales past $4B?
AbbVie sees a megablockbuster in Vraylar. Could a new depression indication push peak sales past $4B?
Endpoints
AbbVie
Vraylar
Allergan
major depressive disorder
FDA
Flag link:
AbbVie submits sNDA to FDA for major depressive disorder therapy
AbbVie submits sNDA to FDA for major depressive disorder therapy
Pharmaceutical Business Review
AbbVie
FDA
cariprazine
major depressive disorder
Flag link:
AbbVie Says Cariprazine Met Primary Endpoint In Phase 3 Study For Major Depressive Disorder
AbbVie Says Cariprazine Met Primary Endpoint In Phase 3 Study For Major Depressive Disorder
NASDAQ
AbbVie
clinical trials
cariprazine
major depressive disorder
Flag link:
Biogen and Sage Present Positive Data for Breakthrough Depression Therapy
Biogen and Sage Present Positive Data for Breakthrough Depression Therapy
BioSpace
Biogen
SAGE Therapeutics
major depressive disorder
postpartum depression
clinical trials
zuranolone
Flag link:
Letter from FDA outlining deficiencies for lead drug causes Axsome stock to crater. Is a CRL on the way?
Letter from FDA outlining deficiencies for lead drug causes Axsome stock to crater. Is a CRL on the way?
Endpoints
Axsome
major depressive disorder
FDA
AXS-05
Flag link:
Sage braces for make-or-break depression data
Sage braces for make-or-break depression data
BioPharma Dive
SAGE Therapeutics
earnings
major depressive disorder
Zulresso
Flag link:
Otsuka and Click Therapeutics Tap Verily to Go Remote with Trial
Otsuka and Click Therapeutics Tap Verily to Go Remote with Trial
Medical Devices and Diagnostics Industry
Otsuka
Click Therapeutics
major depressive disorder
clinical trials
Verily
remote clinical trials
Flag link:
Is Biogen Getting Desperate?
Is Biogen Getting Desperate?
Motley Fool
Biogen
SAGE Therapeutics
major depressive disorder
depression
Flag link:
Sage shares data on retreatment with depression drug zuranolone
Sage shares data on retreatment with depression drug zuranolone
Fierce Biotech
SAGE Therapeutics
zuranolone
clinical trials
major depressive disorder
Flag link:

Pages